Influence of sibutramine on energy expenditure in African American women

Obesity Research

Volumn 9, Issue 4, 2001, Pages 251-256

  Starling, Raymond D ^a,b   Liu, Xiaolan ^a   Sullivan, Dennis H ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Exercise; Heart rate; Post exercise oxygen consumption; Resting energy expenditure; Sibutramine

Indexed keywords

ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE; SIBUTRAMINE;

ADULT; ARTICLE; BASAL METABOLIC RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY METABOLISM; EXERCISE; FEMALE; GENETICS; HEART RATE; HUMAN; NEGRO; OBESITY; OXYGEN CONSUMPTION; PHYSIOLOGY; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; APPETITE DEPRESSANTS; BASAL METABOLISM; CROSS-OVER STUDIES; CYCLOBUTANES; DOUBLE-BLIND METHOD; ENERGY METABOLISM; EXERCISE; FEMALE; HEART RATE; HUMANS; OBESITY; OXYGEN CONSUMPTION; PREMENOPAUSE;

EID: 0035316759     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.29     Document Type: Article

References (25)

1. Allison DB, Edlen-Nezin L, Clay-Williams G. Obesity among African American women: prevalence, consequences, causes, and developing research. Womens Health. 1997;3: 243-74.
2. Albu J, Shur M, Curi M, Murphy L, Heymsfield SB, Pi-Sunyer FX. Resting metabolic rate in obese, premenopausal black women. Am J Clin Nutr. 1997;66:531-8.
3. Forman JN, Miller WC, Szymanski LM, Fernhall B. Differences in resting metabolic rates of inactive obese African American and Caucasian women. Int J Obes Relat Metab Disord. 1998;22:215-21.
4. Foster GD, Wadden TA, Vogt RA. Resting energy expenditure in obese African American and Caucasian women. Obes Res. 1997;5:1-8.
5. Jakicic JM, Wing RR. Differences in resting energy expenditure in African American vs. Caucasian overweight females. Int J Obes Relat Metab Disord. 1998;22:236-42.
6. Weyer C, Snitker S, Bogardus C, Ravussin E. Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr. 1999;70:13-20.
7. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res. 1998;6:1-11.
8. Ryan DH, Kaiser P, Bray GA. Sibutramine: a novel new agent for obesity treatment. Obes Res. 1995;3:553S-9S.
9. Connoley IP, Heal DJ, Stock MJ. A study in rats of the effects of sibutramine on food intake and thermogenesis. Br J Pharmacol. 1995;114:388P.
10. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr. 1998;68:1180-6.
11. Hansen DL, Toubro S, Stock MJ, MacDonald IA, Astrup A. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord. 1999;23:1016-24.
12. Seagle HM, Bessesen DH, Hill JO. Effects of sibutramine on resting metabolic rate and weight loss in overweight women. Obes Res. 1998;6:115-21.
13. Walsh KM, Leen E, Lean MEJ. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes Relat Metab Disord. 1999;23:1009-15.
14. Danforth E Jr. Sibutramine and thermogenesis in humans. Obes Res. 1999;23:1007-8.
15. Børsheim E, Knardahl S, Høstmark AT, Bahr R. Adrenergic control of post-exercise metabolism. Acta Physiol Scand. 1998;162:313-23.
16. Børsheim E, Bahr R, Hansson P, Gullestad L, Hallen J, Sejersted OM. Effect of β-adrenoceptor blockade on post-exercise oxygen consumption. Metabolism. 1994;43:565-71.
17. Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc. 1995;27:1692-7.
18. Ortiz O, Russell M, Daley TL, et al. Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition. Am J Clin Nutr. 1992;55:8-13.
19. Pacy PJ, Cox M, Khalouha M, Elkins S, Robinson ACJ, Garrow JS. Does moderate aerobic activity have a stimulatory effect on 24 h resting energy expenditure: a direct calorimeter study. Int J Food Sci Nutr. 1996;47:299-305.
20. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk for body weight gain. N Engl J Med. 1988;318:467-72.
21. Astrup A, Hansen DL, Lundsgaard C, Toubro S. Sibutramine and energy balance. Int J Obes Relat Metab Disord. 1998;22:S30-5.
22. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ. Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol. 1999;126:1487-95.
23. Børsheim E, Bahr R, Knardahl S. Effect of beta-adrenoceptor stimulation on oxygen consumption and triglyceride/fatty acid cycling after exercise. Acta Physiol Scand. 1998;164: 157-66.
24. Børsheim E, Bahr R, Hostmark AT, Knardahl S. Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling. Metabolism. 1998;47: 439-48.
25. Eston R, Connolly D. The use of rating of perceived exertion for exercise prescription in patients receiving β-blocker therapy. Sports Med. 1996;21:176-90.